This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Boehringer Ingelheim International Gmbh. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: Fridtjof Traulsen: Innovator in Pharmaceutical Solutions
Introduction
Fridtjof Traulsen is a notable inventor based in Biberach, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of storage stable solutions for medical applications. His work has implications for the stability and efficacy of injectable solutions.
Latest Patents
Fridtjof Traulsen holds a patent for a "Storage stable perfusion solution for dihydropteridinones." This patent discloses storage stable aqueous infusible or injectable solutions containing an active substance of general formula (I). The solutions include a physiologically acceptable acid or a mixture of acids sufficient to dissolve the active substance and act as a stabilizer. Additionally, the patent outlines a process for preparing these infusible or injectable solutions.
Career Highlights
Throughout his career, Fridtjof Traulsen has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Boehringer Ingelheim International GmbH and Boehringer Ingelheim Pharma GmbH & Co. KG. His experience in these organizations has contributed to his expertise in developing innovative pharmaceutical solutions.
Collaborations
Fridtjof has collaborated with several professionals in his field, including Detlef Mohr and Claus Veit. These collaborations have likely enriched his work and contributed to the advancements in the pharmaceutical solutions he has developed.
Conclusion
Fridtjof Traulsen is a distinguished inventor whose work in storage stable pharmaceutical solutions has made a significant impact in the medical field. His patent and collaborations reflect his commitment to innovation and excellence in pharmaceutical research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
